Clinical and Economic Implications of Genetic Testing for Warfarin Management
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore how knowing genes that individuals inherit from their
parents can make warfarin dosing more safe and effective. This study is being done to
determine whether providing doctors with data on the genes their patients inherited and
warfarin dosing recommendations based on those genes affects the costs and outcomes of care
and after hospitalization for patients from different ethnic/racial backgrounds, and how
physicians use this information in decision making.